Elicera Therapeutics
Elicera Therapeutics' CSO invited to present at multiple scientific conferences
EBMT-EHA 8th European CAR T-cell Meeting, 12-14 February 2026
Palma de Mallorca, Spain
Title of presentation: NAP CAR T cells for solid tumors
https://www.ebmt.org/events/ebmt-eha-8th-european-car-t-cell-meeting
10th Zurich Immuno-Oncology Conference 2026, 6 March 2026
Zürich, Switzerland
Title of presentation: Optimising CAR-T cells for improved efficacy and reduced toxicity
https://www.usz.ch/en/event/10th-zurich-immuno-oncology-conference-2026/
Onkologidagarna, 17-19 March 2026
Gothenburg, Sweden
Paneldiskussion: Framtidens terapier
https://onkologidagarna.se
Karolinska Cancersymposium, Frontiers in Cancer Research and Therapy, 19-20 March 2026
Stockholm, Sweden
Title of presentation: Optimising CAR-T cells for improved efficacy and reduced toxicity
https://news.ki.se/calendar/conference-frontiers-in-cancer-research-and-therapy-2026
The 4rd Copenhagen symposium on Advances in T cell therapy and Cellular engineering (CATC) 2026, 28-29 May 2026
Kongens Lyngby, Denmark
https://catc.dtu.dk
| Datum | 2026-01-22, kl 09:43 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!